BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fanni D, Manchia M, Lai F, Gerosa C, Ambu R, Faa G. Immunohistochemical markers of CYP3A4 and CYP3A7: a new tool towards personalized pharmacotherapy of hepatocellular carcinoma. Eur J Histochem 2016;60:2614. [PMID: 27349315 DOI: 10.4081/ejh.2016.2614] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Guo C, Guo X, Rong Y, Guo Y, Zhang L. Gene Expression Characteristics of Liver Tissue Reveal the Underlying Pathogenesis of Hepatocellular Carcinoma. Biomed Res Int 2021;2021:9458328. [PMID: 34651050 DOI: 10.1155/2021/9458328] [Reference Citation Analysis]
2 Fanni D, Pinna F, Gerosa C, Paribello P, Carpiniello B, Faa G, Manchia M. Anatomical distribution and expression of CYP in humans: Neuropharmacological implications. Drug Dev Res 2021;82:628-67. [PMID: 33533102 DOI: 10.1002/ddr.21778] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yan J, Shu M, Li X, Yu H, Chen S, Xie S. Prognostic Score-based Clinical Factors and Metabolism-related Biomarkers for Predicting the Progression of Hepatocellular Carcinoma. Evol Bioinform Online 2020;16:1176934320951571. [PMID: 33013158 DOI: 10.1177/1176934320951571] [Reference Citation Analysis]
4 Pellicciari C. Histochemistry as a versatile research toolkit in biological research, not only an applied discipline in pathology. Eur J Histochem 2018;62. [PMID: 30572698 DOI: 10.4081/ejh.2018.3006] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Pellicciari C. Is there still room for novelty, in histochemical papers? Eur J Histochem 2016;60:2758. [PMID: 28076939 DOI: 10.4081/ejh.2016.2758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
6 Zhang F, Wang F, Chen C, Wang T, Hu J, Su R, Li X, Gu B, Tang S, Chen H, Li Y. Prediction of progression of chronic atrophic gastritis with Helicobacter pylori and poor prognosis of gastric cancer by CYP3A4. J Gastroenterol Hepatol 2020;35:425-32. [PMID: 31441961 DOI: 10.1111/jgh.14844] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Yu L, Xu F, Gao L. Predict New Therapeutic Drugs for Hepatocellular Carcinoma Based on Gene Mutation and Expression. Front Bioeng Biotechnol 2020;8:8. [PMID: 32047745 DOI: 10.3389/fbioe.2020.00008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
8 Fanni D, Gerosa C, Loddo C, Castagnola M, Fanos V, Zaffanello M, Faa G. Stem/progenitor cells in fetuses and newborns: overview of immunohistochemical markers. Cell Regen 2021;10:22. [PMID: 34219203 DOI: 10.1186/s13619-021-00084-6] [Reference Citation Analysis]
9 Mao J, Zhao Y, Dong J, Liu C, Xue Q, Ding G, Teng F, Guo W. UBE2T And CYP3A4: hub genes regulating the transformation of cirrhosis into hepatocellular carcinoma. All Life 2021;14:509-21. [DOI: 10.1080/26895293.2021.1933208] [Reference Citation Analysis]
10 Liu J, Han F, Ding J, Liang X, Liu J, Huang D, Zhang C. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis. Biomed Res Int 2021;2021:8849415. [PMID: 34337056 DOI: 10.1155/2021/8849415] [Reference Citation Analysis]
11 Marin JJ, Briz O, Herraez E, Lozano E, Asensio M, Di Giacomo S, Romero MR, Osorio-padilla LM, Santos-llamas AI, Serrano MA, Armengol C, Efferth T, Macias RI. Molecular bases of the poor response of liver cancer to chemotherapy. Clinics and Research in Hepatology and Gastroenterology 2018;42:182-92. [DOI: 10.1016/j.clinre.2017.12.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
12 Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H, Alavian SM, Lankarani KB, Farrokh P, Randel Nyengaard J. Concomitant use of heat-shock protein 70, glutamine synthetase and glypican-3 is useful in diagnosis of HBV-related hepatocellular carcinoma with higher specificity and sensitivity. Eur J Histochem 2018;62:2859. [PMID: 29569872 DOI: 10.4081/ejh.2018.2859] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]